<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02521103</url>
  </required_header>
  <id_info>
    <org_study_id>76</org_study_id>
    <nct_id>NCT02521103</nct_id>
  </id_info>
  <brief_title>Triathlon Tritanium Cone Augments Outcomes Study</brief_title>
  <official_title>A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon TS Total Knee System With Triathlon Tritanium Cone Augments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, open-label, post-market, non-randomized, multi-center clinical
      evaluation of the Triathlon TS Total Knee System with Triathlon Tritanium Cone Augments for
      revision total knee arthroplasty (TKA) in a consecutive series of patients who meet the
      eligibility criteria. The revision rate of the Triathlon Tritanium Cone Augments is expected
      to be less than 2.8% for aseptic loosening of either the Femoral or the Tibial Cone Augments
      at 2 years postoperative.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of cases with revision of the Femoral Cone Augment or Tibial Cone Augment for aseptic loosening</measure>
    <time_frame>2 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of end-of-stem pain in relation to the Triathlon Tritanium Cone Augments location.</measure>
    <time_frame>2 year</time_frame>
    <description>End-of-stem pain is determined via a patient questionnaire; 2 questions are asked in regard to shin and thigh pain location.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of end-of-stem pain.</measure>
    <time_frame>2 year</time_frame>
    <description>End-of-stem pain is determined via a patient questionnaire; 2 questions are asked in regard to shin and thigh pain.
Pain for both the shin and thigh are identified using the following categories:
no pain
pain with extreme activity only
pain with moderate activity
pain with normal activity
pain at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anderson Orthopaedic Research Institute (AORI) classification and Femoral Cone Augment size.</measure>
    <time_frame>intraoperative</time_frame>
    <description>The AORI is a bone defect classification which consists of four Types:
Type I: Metaphyseal bone is intact, with minor bone defects not compromising component stability
Type IIA: There is metaphyseal bone damage and cancellous bone loss in one femoral/tibial condyle; cement reinforcement, bone grafting or metal augmentation is needed.
Type IIB: There is metaphyseal bone damage and cancellous bone loss in both femoral/tibial condyles; cement reinforcement, bone grafting or metal augmentation is needed.
Type III: The metaphyseal bone is deficient and a structural allograft or a custom-made, hinged or revision prosthesis with an extended intramedullary stem is needed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anderson Orthopaedic Research Institute (AORI) classification and Tibial Symmetric Cone Augment size.</measure>
    <time_frame>intraoperative</time_frame>
    <description>The AORI is a bone defect classification which consists of four Types:
Type I: Metaphyseal bone is intact, with minor bone defects not compromising component stability
Type IIA: There is metaphyseal bone damage and cancellous bone loss in one femoral/tibial condyle; cement reinforcement, bone grafting or metal augmentation is needed.
Type IIB: There is metaphyseal bone damage and cancellous bone loss in both femoral/tibial condyles; cement reinforcement, bone grafting or metal augmentation is needed.
Type III: The metaphyseal bone is deficient and a structural allograft or a custom-made, hinged or revision prosthesis with an extended intramedullary stem is needed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anderson Orthopaedic Research Institute (AORI) classification and Tibial Asymmetric Cone Augment size.</measure>
    <time_frame>intraoperative</time_frame>
    <description>The AORI is a bone defect classification which consists of four Types:
Type I: Metaphyseal bone is intact, with minor bone defects not compromising component stability
Type IIA: There is metaphyseal bone damage and cancellous bone loss in one femoral/tibial condyle; cement reinforcement, bone grafting or metal augmentation is needed.
Type IIB: There is metaphyseal bone damage and cancellous bone loss in both femoral/tibial condyles; cement reinforcement, bone grafting or metal augmentation is needed.
Type III: The metaphyseal bone is deficient and a structural allograft or a custom-made, hinged or revision prosthesis with an extended intramedullary stem is needed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Arthroplasty</condition>
  <condition>Replacement</condition>
  <condition>Knee</condition>
  <arm_group>
    <arm_group_label>Triathlon Tritanium Cone Augments</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cases who receive the Triathlon TS Total Knee System with at least one Triathlon Tritanium Cone Augment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Triathlon Tritanium Cone Augments</intervention_name>
    <description>The Triathlon Tritanium Cone Augments are an extension of the Triathlon Total Stabilizer (TS) system, intended to be used as an optional accessory component in primary or revision TKA</description>
    <arm_group_label>Triathlon Tritanium Cone Augments</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved,
             study specific Informed Patient Consent Form.

          -  Patient is a male or non-pregnant female, skeletally mature and age 18 years or older
             at time of study device implantation.

          -  Patient is a candidate for revision of all femoral and tibial components of a total
             knee replacement.

          -  Patient is willing and able to comply with postoperative scheduled clinical and
             radiographic evaluations and rehabilitation.

        Exclusion Criteria:

          -  Patient has a Body Mass Index (BMI) â‰¥ 40.

          -  Patient has an active or suspected latent infection in or about the affected knee
             joint at time of study device implantation.

          -  Patient has a neuromuscular or neurosensory deficiency, which limits the ability to
             evaluate the safety and efficacy of the device.

          -  Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic
             disorder (e.g. Paget's disease) leading to progressive bone deterioration.

          -  Patient is immunologically suppressed or receiving steroids in excess of normal
             physiological requirements (e.g. &gt; 30 days).

          -  Patient has a failed unicondylar knee prosthesis.

          -  Patient has a known sensitivity to device materials.

          -  Patient is a prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine Brozyniak</last_name>
    <phone>201-831-5816</phone>
    <email>christine.brozyniak@stryker.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The CORE Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnie Sumner</last_name>
      <phone>623-537-5658</phone>
      <email>bonnie.sumner@thecoreinstitute.com</email>
    </contact>
    <investigator>
      <last_name>David J Jacofsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gulfcoast Research Institute</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesse D'Alessio</last_name>
      <phone>941-552-7875</phone>
      <email>jdalessio@gulfcoast-research.com</email>
    </contact>
    <investigator>
      <last_name>Edward Stolarski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Garcia</last_name>
      <phone>312-432-2418</phone>
      <email>jane.garcia@rushortho.com</email>
    </contact>
    <investigator>
      <last_name>Craig Della Valle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Heart, St. Joseph Health System</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Sawaya</last_name>
      <phone>734-712-8087</phone>
      <email>ksawaya@michiganheart.com</email>
    </contact>
    <investigator>
      <last_name>Michael Masini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Missouri Orthopaedic Institute</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyssa Shaw</last_name>
      <phone>573-884-8428</phone>
      <email>shawal@health.missouri.edu</email>
    </contact>
    <investigator>
      <last_name>Ajay Aggarwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andres Duque</last_name>
      <phone>609-407-6446</phone>
      <email>andres.duque@rothmaninstitute.com</email>
    </contact>
    <investigator>
      <last_name>Fabio Orozco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alvin Ong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zachary Post, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Orthopaedic Center</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Rutledge</last_name>
      <phone>918-582-6800</phone>
      <email>srutledge@toctulsa.com</email>
    </contact>
    <investigator>
      <last_name>Yogesh Mittal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Medical Branch (UTMB)</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2015</study_first_submitted>
  <study_first_submitted_qc>August 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2015</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

